Logo image of COUR

COURSERA INC (COUR) Stock Fundamental Analysis

USA - NYSE:COUR - US22266M1045 - Common Stock

10.19 USD
+0.07 (+0.69%)
Last: 10/9/2025, 5:06:25 PM
10.25 USD
+0.06 (+0.59%)
After Hours: 10/9/2025, 5:06:25 PM
Fundamental Rating

4

Overall COUR gets a fundamental rating of 4 out of 10. We evaluated COUR against 75 industry peers in the Diversified Consumer Services industry. No worries on liquidiy or solvency for COUR as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, COUR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

COUR had positive earnings in the past year.
COUR had a positive operating cash flow in the past year.
COUR had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: COUR reported negative operating cash flow in multiple years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

COUR has a Return On Assets (-5.19%) which is in line with its industry peers.
The Return On Equity of COUR (-8.12%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.19%
ROE -8.12%
ROIC N/A
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

COUR has a better Gross Margin (54.37%) than 65.33% of its industry peers.
In the last couple of years the Gross Margin of COUR has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for COUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
COUR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, COUR has more shares outstanding
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

COUR has an Altman-Z score of 2.71. This is not the best score and indicates that COUR is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of COUR (2.71) is better than 66.67% of its industry peers.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.71
ROIC/WACCN/A
WACC8.77%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

COUR has a Current Ratio of 2.55. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of COUR (2.55) is better than 80.00% of its industry peers.
A Quick Ratio of 2.55 indicates that COUR has no problem at all paying its short term obligations.
COUR has a Quick ratio of 2.55. This is in the better half of the industry: COUR outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 2.55
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

COUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
COUR shows a small growth in Revenue. In the last year, the Revenue has grown by 7.11%.
The Revenue has been growing by 30.38% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)7.11%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%9.84%

3.2 Future

COUR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.64% yearly.
The Revenue is expected to grow by 6.79% on average over the next years.
EPS Next Y15.5%
EPS Next 2Y15.91%
EPS Next 3Y18.64%
EPS Next 5YN/A
Revenue Next Year7.58%
Revenue Next 2Y6.6%
Revenue Next 3Y6.79%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.26, COUR is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of COUR indicates a somewhat cheap valuation: COUR is cheaper than 62.67% of the companies listed in the same industry.
COUR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.91, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 22.31, the valuation of COUR can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COUR is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of COUR to the average of the S&P500 Index (23.30), we can say COUR is valued inline with the index average.
Industry RankSector Rank
PE 24.26
Fwd PE 22.31
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

COUR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. COUR is cheaper than 70.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.38
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

COUR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
COUR's earnings are expected to grow with 18.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.57
PEG (5Y)N/A
EPS Next 2Y15.91%
EPS Next 3Y18.64%

More info and screens

0

5. Dividend

5.1 Amount

COUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COURSERA INC

NYSE:COUR (10/9/2025, 5:06:25 PM)

After market: 10.25 +0.06 (+0.59%)

10.19

+0.07 (+0.69%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-23 2025-10-23/amc
Inst Owners79.33%
Inst Owner Change0%
Ins Owners6.36%
Ins Owner Change-0.56%
Market Cap1.67B
Analysts74.29
Price Target12.5 (22.67%)
Short Float %4.24%
Short Ratio1.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.93%
Min EPS beat(2)36.12%
Max EPS beat(2)49.74%
EPS beat(4)4
Avg EPS beat(4)133.56%
Min EPS beat(4)36.12%
Max EPS beat(4)356%
EPS beat(8)8
Avg EPS beat(8)1329.89%
EPS beat(12)12
Avg EPS beat(12)910.27%
EPS beat(16)14
Avg EPS beat(16)685.05%
Revenue beat(2)2
Avg Revenue beat(2)0.91%
Min Revenue beat(2)0.22%
Max Revenue beat(2)1.6%
Revenue beat(4)2
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.31%
Revenue beat(12)9
Avg Revenue beat(12)1.29%
Revenue beat(16)11
Avg Revenue beat(16)0.69%
PT rev (1m)0%
PT rev (3m)24.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.34%
EPS NY rev (1m)0%
EPS NY rev (3m)10%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.44%
Valuation
Industry RankSector Rank
PE 24.26
Fwd PE 22.31
P/S 2.31
P/FCF 21.38
P/OCF 14.37
P/B 2.66
P/tB 2.78
EV/EBITDA N/A
EPS(TTM)0.42
EY4.12%
EPS(NY)0.46
Fwd EY4.48%
FCF(TTM)0.48
FCFY4.68%
OCF(TTM)0.71
OCFY6.96%
SpS4.41
BVpS3.83
TBVpS3.67
PEG (NY)1.57
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.19%
ROE -8.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.37%
FCFM 10.81%
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 141.09%
Cap/Sales 5.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.55
Quick Ratio 2.55
Altman-Z 2.71
F-Score5
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)108%
Cap/Depr(5y)109.75%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y15.5%
EPS Next 2Y15.91%
EPS Next 3Y18.64%
EPS Next 5YN/A
Revenue 1Y (TTM)7.11%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%9.84%
Revenue Next Year7.58%
Revenue Next 2Y6.6%
Revenue Next 3Y6.79%
Revenue Next 5YN/A
EBIT growth 1Y39.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year259.82%
EBIT Next 3Y79.6%
EBIT Next 5YN/A
FCF growth 1Y527.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5081.12%
OCF growth 3Y279.12%
OCF growth 5YN/A